共 10 条
[1]
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Sanyal AJ,Campbell-Sargent C,Mirshahi F,et al. Gastroenterology . 2001
[2]
Diabetes[P]. 英国专利:GB201117172D0,2011-11-16
[3]
Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. Petersen KF,Oral EA,Dufour S,et al. The Journal of Clinical Investigation . 2002
[4]
Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease. Facchini FS,Hua NW,Stoohs RA. Gastroenterology . 2002
[5]
Relationship between serum TNF activity and insulin resistance in dairy cows affected with naturally occurring fatty liver. Ohtsuka H,Koiwa M,Hatsugaya A,et al. The Journal of Veterinary Medical Science . 2001
[6]
Troglitazone prevents the rise in visceral adiposity and improves fatty liver associated sulfonylurea therapy———a randomized controlled trial. Katoh S,Hata S,Matsushima M,et al. Metabolism . 2001
[7]
The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic japanese subjects. Goto T,Onuma T,Takebe K,et al. International Journal of Obesity and Related Metabolic Disorders . 1995
[8]
Leptin, troglitazone and the expression of sterol regulatory element binding proteins in liver and pancreatic islets. Kamuta T,Lee Y,Higa M,et al. Proceedings of the National Academy of Sciences of the United States of America . 2000
[9]
TNF-αis not the cause of fatty liver disease in obese diabetic mice. Memon RA,Grunfeld C,Feingold KR. Nature Medicine . 2001
[10]
Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease. Valenti L,Fracanzani AL,Dongiovanni P,et al. Gastroenterology . 2002